Adam Levy
Net worth: 55 437 $ as of 29/09/2026
Net worth: 55 437 $ as of 29/09/2026
Mr. Adam S.
Levy is a Chief Financial Officer at Mineralys Therapeutics, Inc. He is on the Board of Directors at Praxis Bioresearch LLC.
Mr. Levy was previously employed as a Chief Business Officer by Vical, Inc., a Chief Business Officer by Brickell Subsidiary, Inc., a Chief Business Officer by Fresh Tracks Therapeutics, Inc., a Chief Business Officer by Miragen Therapeutics, Inc., a Senior Vice President by Merrill Lynch, Pierce, Fenner & Smith, Inc., a Vice President-Healthcare Investment Banking by Wedbush Securities, Inc., and a Chief Financial Officer by Sanifit Therapeutics SA. He received his undergraduate degree from Cornell University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/03/2026 | 2,206 ( 0% ) | 55 437 $ | 29/09/2026 |
| Companies | Position | Start |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Director of Finance/CFO | 28/02/2022 |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Director/Board Member | 18/09/2023 |
| Companies | Position | End |
|---|---|---|
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Director of Finance/CFO | 31/12/2021 |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Corporate Officer/Principal | 31/12/2019 |
| VIRIDIAN THERAPEUTICS, INC. | Investor Relations Contact | - |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 30/04/2016 |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Corporate Officer/Principal | 31/03/2011 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops and manufactures prescription therapeutics products for treatment of autoimmune, inflammatory and debilitating diseases | Health Technology |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Health Technology |
Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions